These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 24582909)
1. Evaluation of sex differences in cannabinoid dependence. Marusich JA; Lefever TW; Antonazzo KR; Craft RM; Wiley JL Drug Alcohol Depend; 2014 Apr; 137():20-8. PubMed ID: 24582909 [TBL] [Abstract][Full Text] [Related]
2. The impact of gonadal hormones on cannabinoid dependence. Marusich JA; Craft RM; Lefever TW; Wiley JL Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318 [TBL] [Abstract][Full Text] [Related]
3. Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212-2. Brewer AL; Felter CE; Sternitzky AR; Spencer SM Pharmacol Biochem Behav; 2024 Mar; 236():173707. PubMed ID: 38244864 [TBL] [Abstract][Full Text] [Related]
4. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. Stewart JL; McMahon LR J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197 [TBL] [Abstract][Full Text] [Related]
5. Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice. Trexler KR; Nass SR; Crowe MS; Gross JD; Jones MS; McKitrick AW; Siderovski DP; Kinsey SG Drug Alcohol Depend; 2018 Oct; 191():14-24. PubMed ID: 30071445 [TBL] [Abstract][Full Text] [Related]
13. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents. Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154 [TBL] [Abstract][Full Text] [Related]
14. Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Tsou K; Patrick SL; Walker JM Eur J Pharmacol; 1995 Jul; 280(3):R13-5. PubMed ID: 8566091 [TBL] [Abstract][Full Text] [Related]
16. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659 [TBL] [Abstract][Full Text] [Related]
18. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat. Craft RM; Wakley AA; Tsutsui KT; Laggart JD J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934 [TBL] [Abstract][Full Text] [Related]
19. Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat. Wakley AA; Wiley JL; Craft RM Drug Alcohol Depend; 2014 Oct; 143():22-8. PubMed ID: 25131716 [TBL] [Abstract][Full Text] [Related]
20. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction. Dhawan K; Kumar S; Sharma A J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]